Home8WK • FRA
add
Abera Bioscience AB
Previous close
€0.55
Day range
€0.53 - €0.56
Year range
€0.30 - €0.84
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 4.92M | 46.92% |
Operating expense | 5.79M | 59.57% |
Net income | -835.00K | -200.36% |
Net profit margin | -16.97 | -104.46% |
Earnings per share | — | — |
EBITDA | -822.00K | -221.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.18M | 646.41% |
Total assets | 34.07M | 244.48% |
Total liabilities | 5.99M | 338.19% |
Total equity | 28.08M | — |
Shares outstanding | 18.45M | — |
Price to book | 0.36 | — |
Return on assets | -9.03% | — |
Return on capital | -12.09% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -835.00K | -200.36% |
Cash from operations | -4.43M | -1,117.70% |
Cash from investing | -294.00K | -988.89% |
Cash from financing | 19.95M | 29,238.24% |
Net change in cash | 15.23M | 3,092.66% |
Free cash flow | -4.43M | -863.10% |
About
Founded
2012
Website
Employees
5
